We are live on ! Find out more
LA

Lynch & Associates Portfolio holdings

AUM $573M
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+21.74%
3 Year Est. Return
+62.9%
5 Year Est. Return
+80.86%
10 Year Est. Return
+253.75%
AUM
$379M
AUM Growth
-$11.7M
Cap. Flow
+$5.9M
Cap. Flow %
1.56%
Top 10 Hldgs %
39.88%
Holding
116
New
13
Increased
43
Reduced
43
Closed

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.33M
2
DFS
Discover Financial Services
DFS
+$522K
3
TJX icon
TJX Companies
TJX
+$377K
4
DIS icon
Walt Disney
DIS
+$360K
5
MRK icon
Merck
MRK
+$343K

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Miscellaneous 17.48%
3 Healthcare 15.94%
4 Consumer Staples 11.88%
5 Industrials 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGGR icon
101
Capital Group Growth ETF
CGGR
$25.4B
$248K 0.07%
+10,106
New +$257K
KEY icon
102
KeyCorp
KEY
$23.5B
$243K 0.06%
22,565
-2,000
-8% -$22.1K
DFUS
103
Dimensional US Equity ETF
DFUS
$21.6B
$241K 0.06%
+5,170
New +$250K
SPY icon
104
State Street SPDR S&P 500 ETF Trust
SPY
$827B
$239K 0.06%
560
+4
+0.7% +$1.78K
NECB icon
105
Northeast Community Bancorp
NECB
$363M
$221K 0.06%
15,001
RDVY icon
106
First Trust Rising Dividend Achievers ETF
RDVY
$25.5B
$217K 0.06%
+4,717
New +$226K
FTCS icon
107
First Trust Capital Strength ETF
FTCS
$7.98B
$215K 0.06%
+2,919
New +$221K
NKE icon
108
Nike
NKE
$57B
$210K 0.06%
2,200
+1
+0% +$103
CGUS icon
109
Capital Group Core Equity ETF
CGUS
$11.8B
$206K 0.05%
+8,207
New +$213K
ONB icon
110
Old National Bancorp
ONB
$9.89B
$177K 0.05%
12,167
+1,932
+19% +$29.9K
ECBK icon
111
ECB Bancorp
ECBK
$181M
$110K 0.03%
10,000
-3,000
-23% -$36.8K
AGEN
112
Agenus
AGEN
$352M
$48.1K 0.01%
2,130
-209
-9% -$5.93K

Similar funds

Lynch & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Lynch & Associates held 116 positions worth $379M, down 3% from $391M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Lynch & Associates's Q3 2023 filing shows 13 new, 43 increased and 43 reduced positions. Its largest new stake was Visa: 5,797 shares worth $1.33M. The largest sale was Pfizer, an estimated $1.33M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Miscellaneous and Healthcare.

  • Lynch & Associates's largest Q3 2023 buy was Visa: 5,797 shares worth $1.33M.
  • Lynch & Associates added most to Amazon in Q3 2023, an estimated $698K increase.
  • Lynch & Associates's biggest Q3 2023 reduction was Pfizer, cutting an estimated $1.33M.
  • Lynch & Associates's ten largest holdings make up 40% of its $379M portfolio in Q3 2023.
  • Lynch & Associates opened 13 new positions and closed 0 in Q3 2023.
  • Lynch & Associates's portfolio value fell 3% quarter-over-quarter to $379M.

Based on Lynch & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.